drugset / Trial / NCT02731378
Erythropoietin and Iron Supplementation for Patients With Chemotherapy-induced Anaemia
RandomizedParallel-groupOpen-labelTreatment
Summary
A multicentre, randomized, open-label, parallel-group, active controlled non-inferiority study
Timeline
- Start
- 2016-12
- Primary completion
- 2019-04
- Completion
- 2019-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron dextran | Unknown | 100 mg | Intravenous |
| Subject | Iron dextran | Unknown | 200 mg | Intravenous |